SANDOZ DULOXETINE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 8fef807b5cd2183a
Drug Approval Canada Name: SANDOZ DULOXETINE
Product Name: SANDOZ DULOXETINE
Status: Marketed
Status Date: 2016-05-02
Original Market Date: 2016-05-02
Din: 02439948
Drug Class: Human
Dosage Form: Capsule (Delayed Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.16
Atc Original: N06AX21 DULOXETINE
Atc Name: n 06 ax 21
Aig Number: 0152350001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

DULOXETINE (DULOXETINE HYDROCHLORIDE)

30 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8fef807b5cd2183a

Type

Standard